Idarubicin Injection 10 mg/10 mL (3)

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

idarubicin hydrochloride, Quantity: 1 mg/mL

Inapatikana kutoka:

Pfizer (Perth) Pty Ltd

Dawa fomu:

Injection, intravenous infusion

Tungo:

Excipient Ingredients: glycerol; hydrochloric acid; water for injections

Njia ya uendeshaji:

Intravenous Infusion

Vitengo katika mfuko:

1 x 10 mL

Dawa ya aina:

(S1) This Schedule is intentionally blank

Matibabu dalili:

SOUTH AFRICA: Acute non-lymphocytic leukaemia (ANLL), including acute myeloblastic leukaemia (AML) in adults, for remission induction as front-line therapy, or for remission induction in relapsed or refractory patients. ZAVEDOS, in combination with cytarabine, is indicated for the first remission induction-line treatment of previously untreated children with acute myeloid leukaemia (AML)

Bidhaa muhtasari:

Visual Identification: Red - orange, clear, mobile solution; Container Type: Vial; Container Material: PP; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Idhini hali ya:

Listed (Export Only)

Idhini ya tarehe:

2023-02-17